Showing results (871-880 of 966) with videos related to

Sort By:
Pageof 97
Japanese Journal of Infectious Diseases|June 29, 2000
Viral load in Indonesian patients with chronic liver disease and in blood donors infected with different subtypes of hepatitis C virusM I Lusida, Soetjipto, R Handajani, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1997
Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitusY Sumida, H Wada, M Fujii, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 5, 2003
The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitusG Hasegawa, H Obayashi, K Kamiuchi, et al.
Chemical & Pharmaceutical Bulletin|November 12, 1998
Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activitiesH Kubota, A Kakefuda, Y Okamoto, et al.
Oncogene|December 17, 2013
LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascadeI Tanaka, H Osada, M Fujii, et al.
Journal of Neuro-Oncology|April 16, 1998
Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomasM Ohkoudo, H Sawa, M Hara, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitusA Katsuki, Y Sumida, S Murashima, et al.
Oral Oncology|April 8, 2020
Prevalence of human papillomavirus in oral gargles and tonsillar washingsH Cho, T Kishikawa, Y Tokita, et al.
Diabetologia|May 27, 2011
Biliverdin protects against the deterioration of glucose tolerance in db/db miceN Ikeda, T Inoguchi, N Sonoda, et al.
Journal of the American College of Cardiology|March 15, 2000
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failureT Tsutamoto, A Wada, K Maeda, et al.
Pageof 97